VX-745
-
Catalog number2812-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_name5-(2,6-Dichlorophenyl)-2-((2,4-difluorophenyl)thio)-6H-pyrimido[1,6-b]pyridazin-6-one
-
DescriptionVX-745 is a potent and selective inhibitor of p38α (IC₅₀ = 10 nM). It displays 22-fold greater selectivity versus p38β and no inhibition of p38γ. Also blocks TNFα production in LPS-stimulated HWB in vitro (IC₅₀ = 177 nM).
-
CAS Number209410-46-8
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₁₉H₉Cl₂F₂N₃OS
-
Molecular Weight436.26
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (~40 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA potent and selective inhibitor of p38α
-
Storage Condition-20°C
-
Shipping ConditionGel Pack
-
Shelf Life36 months
-
MDL NumberMFCD09834070
-
PubChem CID3038525
-
SMILESC1=CC(=C(C(=C1)Cl)C2=C3C=CC(=NN3C=NC2=O)SC4=C(C=C(C=C4)F)F)Cl
-
InChiInChI=1S/C19H9Cl2F2N3OS/c20-11-2-1-3-12(21)17(11)18-14-5-7-16(25-26(14)9-24-19(18)27)28-15-6-4-10(22)8-13(15)23/h1-9H
-
InChi KeyVEPKQEUBKLEPRA-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameVX-745
-
Alternative nameVX-745
-